New Key Statistics Module, Z-Score and F-Score
NAS:LXRX Key Ratios
Market Cap $ M | 440.76 |
Enterprise Value $ M | 191.43 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.53 |
Price/Sales | 162.73 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 2.00 |
EPS (TTM) $ | -0.83 |
Beneish M-Score | 12.27 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.08 |
EV-to-EBITDA | -1.08 |
PEG | -- |
Shares Outstanding M | 246.24 |
Net Margin (%) | -8,376.55 |
Operating Margin % | -8,045.91 |
Pre-tax Margin (%) | -8,376.55 |
Quick Ratio | 15.56 |
Current Ratio | 15.58 |
ROA % (ttm) | -69.01 |
ROE % (ttm) | -121.61 |
ROIC % (ttm) | -300.92 |
Dividend Yield % | -- |
Altman Z-Score | -4.45 |
LXRX Number of Guru Trades
LXRX Volume of Guru Trades
Gurus Latest Trades with NAS:LXRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LXRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Lexicon Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:LXRX
Total 0- 1